Metoprolol succinate vs tartrate
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Succinate vs Tartrate: Formulation and Release Profile
Metoprolol is available in two main salt forms: metoprolol succinate and metoprolol tartrate. The succinate form is typically formulated as a sustained-release (extended-release) tablet, allowing for once-daily dosing, while the tartrate form is usually an immediate-release tablet, requiring dosing two or more times per day. The extended-release formulation of metoprolol succinate provides a more consistent plasma concentration and beta-blockade throughout the day, which can improve patient compliance and blood pressure control compared to the immediate-release tartrate form Stalin2017Papadopoulos2009.
Clinical Efficacy in Heart Failure and Angina
Studies comparing the two forms in patients with chronic congestive heart failure have found that both metoprolol succinate and tartrate provide similar improvements in cardiac and renal function. However, the succinate sustained-release tablets are more effective at lowering average heart rate in these patients Quan-Y2013Feng-Qi2014. In patients with vasospastic angina, both forms are equally effective in preventing major cardiovascular events such as heart attack, stroke, and death. However, metoprolol succinate is associated with fewer clinically significant angina attacks, while metoprolol tartrate offers greater pharmacoeconomic advantages due to lower cost .
Safety and Tolerability
Both metoprolol succinate and tartrate have similar safety profiles, with no significant differences in adverse drug reactions reported in studies involving patients with chronic heart failure and those with chronic obstructive pulmonary disease (COPD) complicated by heart failure. Both forms are well tolerated, and neither has a significant impact on lung function in patients with COPD .
Hemodynamic Effects
When comparing the hemodynamic effects in patients with congestive heart failure, both forms of metoprolol produce similar acute and chronic changes in cardiac index, systemic vascular resistance, and stroke volume index. The main difference lies in the dosing schedule, with the succinate form allowing for more rapid initiation and once-daily dosing, which may be more convenient for patients .
Structural and Pharmaceutical Differences
At the molecular level, metoprolol succinate and tartrate salts have similar crystal structures, but they behave differently under certain conditions. Metoprolol succinate has a slightly greater cohesive energy and unique reversible lattice expansion/contraction properties, which may influence its stability and formulation as an extended-release product. In contrast, metoprolol tartrate forms an amorphous solid upon cooling from the melt, which takes longer to revert to its original crystal form Paoli2016Bartolucci2009.
Conclusion
Metoprolol succinate and tartrate are both effective beta-blockers for treating heart failure, angina, and hypertension. The main differences are in their dosing schedules and release profiles, with succinate offering the convenience of once-daily dosing and more stable plasma levels, while tartrate may be more cost-effective. Both forms have similar efficacy and safety profiles, making the choice between them dependent on patient needs, compliance, and economic considerations Bocharov2021Quan-Y2013Feng-Qi2014+3 MORE.
Sources and full results
Most relevant research papers on this topic